Evidence map›Paper›PMID 15044535›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.

Hossein Aleyasin, Sean P Cregan, Grace Iyirhiaro, Michael J O'Hare, Steve M Callaghan, Ruth S Slack, David S Park

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 108 citations in OpenAlex.

  1. MIF Tautomerase Inhibition Protects Neurons From Immune-Mediated Cell Death.Neurology(R) neuroimmunology & neuroinflammation · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Regulation of the VHL/HIF-1 pathway by DJ-1.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The bad, the good, and the ugly about oxidative stress.Oxidative medicine and cellular longevity · 2012
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hossein AleyasinOttawa Health Research Institute, Neurosciences, East Division, Ottawa, Ontario, Canada K1H 8M5.
Sean P Cregan
Grace Iyirhiaro
Michael J O'Hare
Steve M Callaghan
Ruth S Slack
David S Park
Health Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have shown that DNA damage-evoked death of primary cortical neurons occurs in a p53 and cyclin-dependent kinase-dependent (CDK) manner. The manner by which these signals modulate death is unclear. Nuclear factor-kappaB (NF-kappaB) is a group of transcription factors that potentially interact with these pathways. Presently, we show that NF-kappaB is activated shortly after induction of DNA damage in a manner independent of the classic IkappaB kinase (IKK) activation pathway, CDKs, ATM, and p53. Acute inhibition of NF-kappaB via expression of a stable IkappaB mutant, downregulation of the p65 NF-kappaB subunit by RNA interference (RNAi), or pharmacological NF-kappaB inhibitors significantly protected against DNA damage-induced neuronal death. NF-kappaB inhibition also reduced p53 transcripts and p53 activity as measured by the p53-inducible messages, Puma and Noxa, implicating the p53 tumor suppressor in the mechanism of NF-kappaB-mediated neuronal death. Importantly, p53 expression still induces death in the presence of NF-kappaB inhibition, indicating that p53 acts downstream of NF-kappaB. Interestingly, neurons cultured from p65 or p50 NF-kappaB-deficient mice were not resistant to death and did not show diminished p53 activity, suggesting compensatory processes attributable to germline deficiencies, which allow p53 activation still to occur. In contrast to acute NF-kappaB inhibition, prolonged NF-kappaB inhibition caused neuronal death in the absence of DNA damage. These results uniquely define a signaling paradigm by which NF-kappaB serves both an acute p53-dependent pro-apoptotic function in the presence of DNA damage and an anti-apoptotic function in untreated normal neurons.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsCamptothecinCell Cycle ProteinsCell DeathCells, CulturedCell SurvivalDNA-Binding ProteinsDNA DamageEnzyme InhibitorsGene Expression RegulationI-kappa B ProteinsMiceMice, KnockoutNeuronsNF-kappa BAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseCamptothecinCell Cycle ProteinsDNA-Binding ProteinsEnzyme InhibitorsI kappa B beta proteinI-kappa B ProteinsNF-kappa BNF-KappaB Inhibitor alphaNF-kappa B p50 SubunitNfkbia protein, mouseProtein Serine-Threonine KinasesTopoisomerase I InhibitorsTranscription Factor RelATumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID15044535
PMCPMC6729853
OpenAlexW2079201863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.